Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04624698 · ClinicalTrials.gov registry record · NA
iStent Inject New Enrollment Post-Approval Study
A NA study of Glaucoma and Glaucoma Open-Angle, sponsored by Glaukos Corporation.
- Active
- Registry status
- NA
- Development phase
- 358
- Enrollment target
- 3
- Study locations
NCT04624698 is a NA study of Glaucoma and Glaucoma Open-Angle that is active but no longer recruiting, run by Glaukos Corporation. The registered enrollment target is 358 participants, below the 907-participant average among 92 other Glaucoma trials with a reported enrollment target (61% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT04624698, a NA study of Glaucoma and Glaucoma Open-Angle, is active but no longer recruiting, sponsored by Glaukos Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 358 participants
- Enrollment target
- 3
- Study locations
Study Summary
Study to evaluate the rate of clinically relevant complications associated with iStent inject placement in the post-market setting.
Conditions Studied
Interventions
- DEVICE iStent Inject Implantation
Study Locations (3)
Arizona
- Eye Doctors of Arizona, PLLC - Phoenix
California
- Wolstan and Goldberg Eye Associates - Torrance
Texas
- Glaucoma Associates of Texas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2020-09-22 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04624698
The ClinicalTrials.gov registry entry for NCT04624698 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 358 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 907-participant average among 92 other Glaucoma trials with a reported enrollment target (61% lower). The listed sponsor is Glaukos Corporation, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which iStent Inject Implantation is the first listed.
NCT04624698 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, California, Texas.
Frequently Asked Questions
What is clinical trial NCT04624698 about?
NCT04624698 is a clinical study titled "iStent Inject New Enrollment Post-Approval Study". Study to evaluate the rate of clinically relevant complications associated with iStent inject placement in the post-market setting.
What is the current status of trial NCT04624698?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 358 participants. The study started on 2020-09-22. Estimated completion is 2026-05.
What conditions does trial NCT04624698 study?
This clinical trial studies the following conditions: Glaucoma, Glaucoma Open-Angle.
What interventions are being tested in trial NCT04624698?
The interventions under investigation include: iStent Inject Implantation (DEVICE).
Who is sponsoring clinical trial NCT04624698?
This trial is sponsored by Glaukos Corporation, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04624698 being conducted?
This trial has 3 study locations across Arizona, California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Hyperbaric Oxygen Therapy for Optic Neuropathies
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.